Jason McCarthy
Analyst, Maxim Group
Replay available
Acurx Pharmaceuticals, Inc. (ACXP) Q4 2025 Earnings Call
Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) Q4 2025 earnings conference call, held 2026-03-13. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
David Lucci
President and CEO
Rob Sawa
Chief Financial Officer
Dr. Michael Silverman
Medical Director, Accurex Pharmaceuticals
James Maboy
Analyst, Alliance Global Partners
Bob DeLucia
Executive Chairman
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Acurx Pharmaceuticals, Inc..
Replay transcript excerpt
WEBVTT NOTE Transcription provided by Deepgram Request Id: 01a04268-6d22-7f41-9e09-90f95d23e6af Created: 2026-08-27T08:48:56.239Z Duration: 1978.0702 Channels: 1 00:00:01.120 -- 00:00:04.240 Greetings, and welcome to Acurx Pharmaceuticals Conference Call 00:00:04.240 -- 00:00:06.720 to discuss Full Year and Fourth Quarter twenty 00:00:06.720 -- 00:00:08.559 twenty five Financial Results. 00:00:08.960 -- 00:00:11.120 At this time, all participants are in a 00:00:11.120 -- 00:00:13.975 listen only mode. A question and answer session 00:00:13.975 -- 00:00:15.894 will follow the formal presentation. 00:00:22.775 -- 00:00:25.175 As a reminder, this conference is being recorded. 00:00:26.090 -- 00:00:28.170 It is now my pleasure to introduce your 00:00:28.170 -- 00:00:30.730 host, Rob Salwa, Chief Financial Officer. 00:00:30.890 -- 00:00:32.409 Thank you. Please go ahead. 00:00:34.330 -- 00:00:36.970 Thank you, Donna. Good morning, and welcome to 00:00:36.970 -- 00:00:37.370 our call. 00:00:38.585 -- 00:00:40.825 This morning we issued a press release providing 00:00:40.825 -- 00:00:44.025 financial results and company highlights for the year 00:00:44.025 -- 00:00:46.665 ended in fourth quarter twenty twenty five, 00:00:47.305 -- 00:00:51.225 which is available on our website at acorexpharma.com. 00:00:52.800 -- 00:00:55.040 Joining me today are Bob DeLuccia, 00:00:55.440 -- 00:00:57.360 Executive Chairman of Acurx 00:00:57.680 -- 00:00:59.520 Doctor. Michael Silverman, 00:00:59.680 -- 00:01:01.440 Medical Director of Acurx, 00:01:01.760 -- 00:01:03.840 who will be available for questions related to 00:01:03.840 -- 00:01:06.080 our R and D activities and strategy 00:01:06.160 -- 00:01:07.840 during the Q and A period 00:01:08.345 -- 00:01:11.545 and David Lucci, President ...